Skip to content

Correlating Time-Lapse Parameters Detected by the Eeva™ System With Comprehensive Chromosome Screening Results

Correlating Time-Lapse Parameters Detected by the Eeva™ System With Comprehensive Chromosome Screening Results,Implantation and Live Birth

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01635049
Acronym
CCS
Enrollment
110
Registered
2012-07-06
Start date
2012-06-30
Completion date
2014-12-31
Last updated
2015-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

in vitro fertilization, assisted reproduction techniques, noninvasive imaging of embryos, time lapse imaging of embryos, traditional morphological grading of embryos, prediction of blastocysts, infertility, preimplantation genetic diagnosis, comprehensive chromosome screening

Brief summary

The purpose of this research study protocol is to collect imaging data on embryos followed to blastocyst stage (Day 5-6) and correlate Eeva System parameters with comprehensive chromosome screening (CCS) results, implantation and live birth.

Detailed description

The present study was designed to determine if there is a correlation between the Eeva System parameters and CCS results. Embryos will be selected for transfer based on CCS results and morphology. The Clinical site will have no access to the Eeva analysis at the time of the transfer.

Interventions

None listed

Sponsors

Progyny, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
No minimum to 43 Years
Healthy volunteers
No

Inclusion criteria

* Subject is ≤43 years of age. * Women undergoing fresh IVF treatment using her own eggs or donor eggs and undergoing CCS, as recommended based on medical need by the clinical site reproductive endocrinologist. * Fertilization using only ejaculated sperm (fresh or frozen) - no surgically retrieved sperm. * Willing to have all 2PN embryos monitored by Eeva * Not previously enrolled in this study. * No concurrent participation in another clinical study. * Willing to comply with study protocol and procedures and able to speak English. * Willing to provide written informed consent.

Exclusion criteria

* BMI ≥ 40 * Prior IVF cycle with \< 4 x 2PN * Diminished ovarian reserve as demonstrated by any one of the following: * BAFC \< 6 at time of cycle start * Maximum prior FSH \> 15 * AMH \< 0.5

Design outcomes

Primary

MeasureTime frameDescription
Eeva time-lapse parameters and CCS5-6 daysAnalyse the correlation of time-lapse parameters collected by the Eeva System and comprehensive chromosome screening (CCS) results.

Secondary

MeasureTime frame
Correlation of time-lapse parameters collected by the Eeva System and implantation rate.6 weeks
Correlation of time-lapse parameters collected by the Eeva System and ongoing pregnancy rate7 - 8 weeks
Correlation of time-lapse parameters collected by the Eeva System and clinical pregnancy rate6 weeks
Correlation of time-lapse parameters collected by the Eeva System and spontaneous miscarriage ratelive birth
Correlation of time-lapse parameters collected by the Eeva System and multiple pregnancy ratelive birth
Correlation of time-lapse parameters collected by the Eeva System and delivery ratelive birth

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026